| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $36.3M | +8.6% | +6.1% |
| Gross Profit | $18.3M | +26.4% | +407.7% |
| R&D Expense | $1.3M | +44.8% | +8.3% |
| SG&A Expense | $9.3M | -12.2% | -27.5% |
| Operating Income | -$503K | +90.6% | +98.5% |
| Pre-tax Income | $27.0M | +169.2% | +485.0% |
| Income Tax | -$1.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $784.2M | -1.3% | -9.0% |
| Short-term Investments | $40.0M | +0.0% | — |
| Accounts Receivable | $27.1M | +1.8% | +32.3% |
| Inventory | $48.2M | +14.3% | +1.9% |
| Current Assets | $922.2M | -0.5% | -3.9% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $14.0M | — | — |
| Capital Expenditures | $23.6M | — | — |
| Investing Cash Flow | -$79.3M | — | — |
| Financing Cash Flow | -$12.5M | — | — |
| Free Cash Flow | -$9.5M | — | — |
| -150.7% |
| +51.4% |
| Net Income | $26.0M | +165.4% | +210.9% |
| EPS (Basic) | $0.07 | +170.0% | +250.0% |
| EPS (Diluted) | $0.07 | +170.0% | +250.0% |
| $1.18B |
| +0.3% |
| -0.5% |
| Current Liabilities | $41.1M | +9.2% | +3.8% |
| Total Liabilities | $46.4M | +3.0% | -12.2% |
| Stockholders' Equity | $1.08B | +0.0% | +0.1% |